News & Perspective

Aug 31, 2018

Aug 31, 2018

ASP Scan (Weekly) for Aug 31, 2018

C diff testing in the NICU
Resistant gonorrhea in Europe
ESBL bacteria in sprouts
Antibiotic resistance risk factors
Business case for stewardship
UK FMT C diff guidelines
Pharmacist-led stewardship
Typhoid vaccine as stewardship tool
Web training for antibiotic stewardship
Chest x-ray and pneumonia
New antibiotic for intra-abdominal infections
Bedaquiline for MDR-TB
Australian stewardship study

Aug 10, 2018

Aug 10, 2018

ASP Scan (Weekly) for Aug 10, 2018

Cost of antibiotic resistance
Antibiotic resistance in Australia
New antibiotic for pneumonia, skin infections
Ventilator-associated pneumonia risk factors
Autism and early antibiotic exposure
Stewardship standouts
AMR innovation competition
Phased stewardship strategy
Antibiotic use in the Amazon

Sep 08, 2017

Sep 08, 2017

ASP Scan (Weekly) for Sep 08, 2017

ESBL-E in pregnant women
Antimicrobial resistance in Southeast Asia
Precision antimicrobials
Money for antibiotic development
Canada AMR framework
Pharmacist stewardship
CRE treatment

Aug 22, 2017

Aug 22, 2017

Flu Scan for Aug 22, 2017

Prior year flu vaccination
H5N8 in South Africa
Global flu hot spots

Apr 18, 2019

Apr 18, 2019

New metric aims to simplify how global resistance is measured

The Drug Resistance Index shows disparities in the effectiveness of antibiotics in high- and low-income countries.

Oct 07, 2011

Oct 07, 2011

Cuba, Southeast Asia among active spots for flu

(CIDRAP News) – Though influenza activity is low in most nations, some are seeing active transmission, including Cuba, Bolivia, Cameroon, and parts of Southeast Asia, the World Health Organization said today in an update.

Cuba and El Salvador have reported increasing circulation of influenza A (H3N2), a strain that peaked in Honduras in the middle of August.

May 18, 2011

May 18, 2011

Experts: Regulatory issues are main reason for keeping smallpox virus

(CIDRAP News) – When the World Health Assembly (WHA) considers the fate of the remaining stocks of smallpox virus this week, the debate is likely to be framed in part by a report from a group of independent experts that says the only strong reason for keeping the virus is to satisfy strict regulatory requirements for new vaccines and antivirals.

Pages

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»